These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1687076)

  • 1. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.
    Masclee AA; Jansen JB; Lamers CB
    Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide.
    Grosman I; Simon D
    Am J Gastroenterol; 1990 Sep; 85(9):1061-72. PubMed ID: 1975156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative treatment of acute pancreatitis: the use of somatostatin.
    Ladas SD; Raptis SA
    Hepatogastroenterology; 1992 Oct; 39(5):466-9. PubMed ID: 1360937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Kaplan O
    J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders.
    Dhar A; Chawla YK
    Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
    Delmont J; Hastier P; Dumas R
    Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.
    Paran H; Klausner J; Siegal A; Graff E; Freund U; Kaplan O
    J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine disorders of the gastroenteropancreatic system. Clinical applications of the somatostatin analogue SMS 201-995. April 2-4, 1986, San Diego, California.
    Am J Med; 1986 Dec; 81(6B):1-101. PubMed ID: 2879445
    [No Abstract]   [Full Text] [Related]  

  • 12. [Future therapeutic potentials of somatostatin].
    Rubiés-Prat J
    Med Clin (Barc); 1983 Feb; 80(3):142-3. PubMed ID: 6132031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Theoretical and physiopharmacological bases of the somatostatin treatment in digestive diseases].
    Consolo F; Pustorino S
    Minerva Chir; 1992 Apr; 47(8):723-9. PubMed ID: 1351277
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin and octreotide in the management of acute variceal hemorrhage.
    Avgerinos A; Armonis A; Raptis S
    Hepatogastroenterology; 1995 Apr; 42(2):145-50. PubMed ID: 7672763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Somatostatin and octreotide in therapy of gastrointestinal diseases].
    Stöckmann F
    Z Gastroenterol Verh; 1991 Mar; 26():166-70. PubMed ID: 1714136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of somatostatin in gastroenterology].
    Lamers CB
    Ned Tijdschr Geneeskd; 1986 May; 130(20):908-11. PubMed ID: 2873515
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic applications of somatostatin and its analog, octreotide].
    Harris AG; Kokoris SP
    Presse Med; 1993 Apr; 22(15):724-33. PubMed ID: 8099737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin and octreotide in gastroenterology.
    Burroughs AK; McCormick PA
    Aliment Pharmacol Ther; 1991 Aug; 5(4):331-41. PubMed ID: 1685674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of somatostatin and octreotide in the management of acute pancreatitis.
    Büchler MW; Binder M; Friess H; Malfertheiner P
    Digestion; 1994; 55 Suppl 1():16-9. PubMed ID: 7907565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.